RecruitingACTRN12622000043730

The effect of subcutaneous glyceryl trinitrate on radial artery diameter and the utility in radial access coronary angiography


Sponsor

Royal Brisbane & Women's Hospital

Enrollment

300 participants

Start Date

Aug 1, 2022

Study Type

Interventional

Conditions

Summary

A transradial arterial approach is being used more frequently for coronary angiography due to the lower vascular complications and lower bleeding rates reported in recent large trials. Radial artery spasm, subclavian tortuosity and the increased technical difficulty of puncturing a smaller and more mobile artery are causes for access failure. This prospective randomised placebo controlled trial aims to look at the role of subcutaneous glyceryl trinitrate, as a vasodilatory agent, injected prior to arterial puncture to improve the technique. Radial artery diameter change will be assessed using ultrasound at the site of injection as well as the contralateral side to review for a systemic effect. Time to successful arterial access will be recorded and patient satisfaction in the form of pain scores will also be recorded.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

Coronary angiography — a procedure to look at the blood vessels of the heart — is increasingly performed via the wrist (radial artery) rather than the groin, because it has fewer bleeding complications. However, the radial artery can go into spasm during the procedure, making it harder to access. One potential solution is to inject a small amount of glyceryl trinitrate (GTN, a vasodilator) under the skin near the artery before inserting the catheter, to help the artery relax and widen. This randomised placebo-controlled trial will compare subcutaneous GTN injection versus a placebo injection before radial artery puncture. Ultrasound will measure changes in artery diameter, and the study will also record how long it takes to successfully access the artery and whether patients experience more or less pain. You may be eligible if you are having a planned (non-emergency) coronary angiogram via the radial (wrist) approach. People with low blood pressure, emergency heart attacks (STEMI), certain heart conditions, known sensitivity to GTN, glaucoma, prior stroke, or who have recently taken erectile dysfunction medications would not be eligible. This is a simple, practical study that could directly improve the comfort and success rate of a very common cardiac procedure.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The intervention will be a subcutaneous injection of glyceryl trinitrate (GTN) prior to radial artery puncture as part of a coronary angiogram. One millilitre (1ml) GTN (500 micrograms / millilitre) w

The intervention will be a subcutaneous injection of glyceryl trinitrate (GTN) prior to radial artery puncture as part of a coronary angiogram. One millilitre (1ml) GTN (500 micrograms / millilitre) with 1ml lidocaine 2% will be used once only. This injection will be provided by the blinded operator performing the procedure.


Locations(1)

The Prince Charles Hospital - Chermside

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12622000043730